Re-export Of Medicines Hit Slovak Pharma Sector
News: The Slovak State Institute for Drug Control (ŠÚKL) has banned the re-export of medicines for treatment of epilepsy, cardio-vascular diseases, neurological diseases and heart attack as there is no therapeutic alternative available in the country, reports The Slovak Spectator. Currently, parallel trade in drugs has reached a level where it is virtually impossible to get certain medicines for the citizens of Slovakia, according to Ondrej Suke, the first vice president of the Slovak Chamber of Pharmacists (SleK). Some Slovak distribution companies purchase medicines from local pharmacies and re-export them to Germany, the Czech Republic or Scandinavian countries, where these drugs are much more expensive. Such medicines are generally prescribed by medical practitioners and covered by health insurance.